POSA150 Cost-Effectiveness Analysis of First-Line (1L) Systemic Treatments in Advanced Renal Cell Carcinoma (aRCC) in France

Autor:	S Tempelaar, S Kroep, L Marie, L Juban, M Kurt, F Ejzykowicz, JR May, AF Gaudin, N Dhanji, S Branchoux
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S63
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69e77ae52257e443670a70a48ead0579 https://doi.org/10.1016/j.jval.2021.11.291 Zobrazit plný text záznamu Full Text from ScienceDirect